Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis.

Abstract

AIM:

To investigate the efficacy and safety profile of pancreatic duct (PD) stent placement for prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP).

METHODS:

We performed a search of MEDLINE, EMBASE, and Cochrane Library to identify randomized controlled clinical trials of prophylactic PD stent placement after ERCP. RevMan 5 software provided by Cochrane was used for the heterogeneity and efficacy analyses, and a meta-analysis was performed for the data that showed homogeneity. Categorical data are presented as relative risks and 95% confidence intervals (CIs), and measurement data are presented as weighted mean differences and 95%CIs.

RESULTS:

The incidence rates of severe pancreatitis, operation failure, complications and patient pain severity were analyzed. Data on pancreatitis incidence were reported in 14 of 15 trials. There was no significant heterogeneity between the trials (I(2) = 0%, P = 0.93). In the stent group, 49 of the 1233 patients suffered from PEP, compared to 133 of the 1277 patients in the no-stent group. The results of this meta-analysis indicate that it may be possible to prevent PEP by placing a PD stent.

CONCLUSION:

PD stent placement can reduce postoperative hyperamylasemia and might be an effective and safe option to prevent PEP if the operation indications are well controlled.

• Authors: Jin-He Fan, Jun-Bo Qian, Ya-Min Wang, Rui-Hua Shi, Cheng-Jin Zhao
• Journal: World journal of gastroenterology (World J Gastroenterol) Vol. 21 Issue 24 Pg. 7577-83 (Jun 28 2015) ISSN: 2219-2840 [Electronic] United States
• PMID: 26140006 (Publication Type: Journal Article, Meta-Analysis, Review)

Topics

• Chi-Square Distribution
• Cholangiopancreatography, Endoscopic Retrograde (adverse effects, instrumentation)
• Humans
• Incidence
• Odds Ratio
• Pancreatitis (diagnosis, epidemiology, prevention & control)
• Prosthesis Design
• Randomized Controlled Trials as Topic
• Risk Factors
• Stents
• Treatment Outcome